IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

Historical Holders from Q3 2020 to Q3 2025

Type / Class
Debt / NOTE 1.500% 6/1
Market price (% of par)
89.5%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal
$170,823,077
Total reported market value
$177,255,350
Principal change
+$3,389,000
Market value change
-$449,580
Number of holders
10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
11 filings reported holding 46333XAH1 - IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1.
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 has 10 institutional bondholders. These institutions hold $170,823,077 principal (par value) of the bond.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2025 Q3 $170,823,077 $177,255,350 -$449,580 89.5% 10
2025 Q2 $167,434,077 $168,923,031 -$617,814 84.82% 11
2025 Q1 $165,440,927 $177,805,855 -$118,800 88.89% 13
2024 Q4 $162,485,927 $181,412,896 -$5,360,726 91.88% 15
2024 Q3 $174,660,250 $155,061,380 -$26,716,158 88.54% 19
2024 Q2 $199,579,000 $188,232,680 -$1,533,998 93.95% 19
2024 Q1 $197,210,000 $200,950,767 -$4,539,464 101.32% 26
2023 Q4 $197,783,681 $214,752,759 -$57,789,639 108.35% 23
2023 Q3 $253,984,309 $234,677,877 +$47,093,082 97.69% 21
2023 Q2 $195,096,314 $199,278,621 -$3,823,182 102.09% 17
2023 Q1 $199,068,000 $199,949,244 +$3,862,775 100.21% 23
2022 Q4 $193,332,792 $211,892,625 +$3,261,450 109.38% 25
2022 Q3 $172,488,037 $168,248,167 -$19,039,698 101.75% 24
2022 Q2 $191,137,250 $198,228,023 -$2,926,303 107.57% 21
2022 Q1 $193,608,500 $218,760,621 -$1,589,710 117.78% 19
2021 Q4 $195,546,000 $213,593,434 -$9,012,218 113.58% 19
2021 Q3 $198,153,834 $243,379,250 +$25,811,330 120.74% 19
2021 Q2 $176,649,934 $215,917,000 +$8,625,012 119.72% 18
2021 Q1 $169,573,934 $196,167,489 -$3,397,974,273 113.2% 17
2020 Q4 $173,803,000 $188,929,835 +$1,151,873 112.59% 17
2020 Q3 $167,111,321 $163,526,000 +$163,522,498 97.8% 17